🇺🇸 FDA
Pipeline program

Postoperative radiotherapy

2025-0846

Unknown other active

Quick answer

Postoperative radiotherapy for Oral Tongue Squamous Cell Carcinoma is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Oral Tongue Squamous Cell Carcinoma
Phase
Unknown
Modality
other
Status
active

Clinical trials